Cholesterol is a biological molecule that is essential for cellular life. It has unique features in terms of molecular structure and function, and plays an important role in determining the structure and properties of cell membranes. One of the most recognized functions of cholesterol is its ability to increase the level of lipid packing and rigidity of biological membranes while maintaining high levels of lateral mobility of the bulk lipids, which is necessary to sustain biochemical signaling events. There is increased interest in designing bioactive peptides that can act as effective antimicrobial agents without causing harm to human cells. For this reason, it becomes relevant to understand how cholesterol can affect the interaction between bioactive peptides and lipid membranes, in particular by modulating the peptides’ ability to penetrate and disrupt the membranes through these changes in membrane rigidity. Here we discuss cholesterol and its role in modulating lipid bilayer properties and discuss recent evidence showing how cholesterol modulates bioactive peptides to different degrees.
Bioactive peptides have emerged as promising therapeutic agents with antimicrobial, antifungal, antiparasitic, and, recently, antitumoral properties with a mechanism of action based on membrane destabilization and cell death, often involving a conformational change in the peptide. This biophysical study aims to provide preliminary insights into the membrane-level antitumoral mode of action of crotalicidin, a cationic host defense peptide from rattlesnake venom, toward breast cancer cell lines. The lipid composition of breast cancer cell lines was obtained after lipid extraction and quantification to prepare representative cell membrane models. Membrane–peptide interaction studies were performed using differential scanning calorimetry and Fourier-transform infrared spectroscopy. The outcome evidences the potential antitumoral activity and selectivity of crotalicidin toward breast cancer cell lines and suggests a mechanism initiated by the electrostatic interaction of the peptide with the lipid bilayer surface and posterior conformation change with membrane intercalation between the acyl chains in negatively charged lipid systems. This research provides valuable information that clears up the antitumoral mode of action of crotalicidin.
The limited selectivity of antimicrobial peptides (AMPs) can lead to unintended damage to healthy eukaryotic cells, a process strongly influenced by membrane physicochemical properties. Cholesterol (CHO) is a key regulator of lipid packing, membrane order, and bilayer mechanical stability; however, its role in modulating AMP-membrane interactions remain incompletely understood. Here, we examine how CHO alters peptide-membrane interactions at the molecular level using eukaryotic membrane models composed of phosphatidylcholine, sphingomyelin, and increasing CHO fractions. Fourier-transform infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC), isothermal titration calorimetry (ITC), and fluorescence spectroscopy were employed to probe both structural and thermodynamic changes upon interaction with the human cathelicidin LL-37. FT-IR and DSC revealed that LL-37 preferentially perturbs sphingomyelin-enriched membranes, inducing shifts in phase transition temperatures and signatures of domain segregation. These perturbations were pronounced in the absence of CHO and remained detectable up to 10 mol% CHO, but were markedly attenuated at 20 mol% CHO. ITC measurements confirmed a higher binding affinity of LL-37 for sphingomyelin-rich regions, whereas fluorescence permeabilization assays demonstrated a progressive increase in membrane resistance to peptide-induced disruption with increasing CHO content. Collectively, these results suggest that LL-37 preferentially partitions into cholesterol-poor membrane domains, destabilizing their structure. In contrast, cholesterol incorporation stabilizes the surface of cholesterol-rich domain without necessarily promoting peptide anchoring within the bilayer. This study provides mechanistic insights into AMP cytotoxicity toward eukaryotic membranes and underscores cholesterol's protective role offering guidance for designing peptides with enhanced therapeutic selectivity.